Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ocular Therapeutix (OCUL) Other Non Operating Income: 2012-2024

Historic Other Non Operating Income for Ocular Therapeutix (OCUL) over the last 12 years, with Dec 2024 value amounting to -$27.9 million.

  • Ocular Therapeutix's Other Non Operating Income was N/A to -$938,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$29.7 million, marking a year-over-year change of. This contributed to the annual value of -$27.9 million for FY2024, which is 296.97% down from last year.
  • Ocular Therapeutix's Other Non Operating Income amounted to -$27.9 million in FY2024, which was down 296.97% from $14.2 million recorded in FY2023.
  • Over the past 5 years, Ocular Therapeutix's Other Non Operating Income peaked at $14.2 million during FY2023, and registered a low of -$86.2 million during FY2020.
  • In the last 3 years, Ocular Therapeutix's Other Non Operating Income had a median value of -$1,000 in 2022 and averaged -$4.6 million.
  • As far as peak fluctuations go, Ocular Therapeutix's Other Non Operating Income plummeted by 2,099.74% in 2020, and later surged by 1,419,100.00% in 2023.
  • Over the past 5 years, Ocular Therapeutix's Other Non Operating Income (Yearly) stood at -$86.2 million in 2020, then skyrocketed by 100.00% to $1,000 in 2021, then crashed by 200.00% to -$1,000 in 2022, then spiked by 1,419,100.00% to $14.2 million in 2023, then slumped by 296.97% to -$27.9 million in 2024.